With durable competitive advantages, strong credit, and a well-stocked pipeline of new pharmaceuticals, Roche offers a 40% upside and a 7% annual return to investors willing to swallow this pill.
Rundown
Company name:Β Roche Holding AG
Ticker:Β RO (Swiss Exchange)
Type: Common stock bearer shares (with voting rights)
52-week range:Β SFr341-439
Market cap:Β SFr261β¦
Keep reading with a 7-day free trial
Subscribe to ππππ’πππ to keep reading this post and get 7 days of free access to the full post archives.